RxSight, Inc. Financing Cash Flow
RxSight, Inc. (RXST) reported Financing Cash Flow of $326.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- RxSight, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $662.00K, a 67.94% decline year-over-year.
- RxSight, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$336.00K.
- RxSight, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.06M, a 64.28% decline year-over-year.
- RxSight, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$530.00K, a 160.36% decline year-over-year.
- RxSight, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $1.86M, a 98.49% decline from fiscal 2024.
- RxSight, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $123.32M, a 100.44% increase from fiscal 2023.
- RxSight, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $61.52M, a 871.64% increase from fiscal 2022.
- RxSight, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $6.33M, a 95.39% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $662.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $326.00K 10-Q · filed 2026-08-05 | $1.39M derived: sum of 3 quarters · filed 2026-08-05 | $859.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$336.00K 10-Q · filed 2026-05-06 | $727.00K derived: sum of 2 quarters · filed 2026-05-06 | $197.00K derived: sum of 3 quarters · filed 2026-05-06 | $2.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $533.00K derived: sum of 2 quarters · filed 2026-02-25 | $2.60M derived: sum of 3 quarters · filed 2026-08-05 | $1.86M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$530.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.53M derived: sum of 2 quarters · filed 2026-08-05 | $800.00K 10-Q · filed 2025-11-05 | $3.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.33M 10-Q · filed 2026-08-05 | $4.31M derived: sum of 3 quarters · filed 2026-08-05 | $5.18M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$735.00K 10-Q · filed 2026-05-06 | $2.24M derived: sum of 2 quarters · filed 2026-05-06 | $3.12M derived: sum of 3 quarters · filed 2026-05-06 | $114.59M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.85M derived: sum of 2 quarters · filed 2026-02-25 | $115.33M derived: sum of 3 quarters · filed 2026-02-25 | $123.32M 10-K · filed 2026-02-25 |
| 2024-09-30 | $878.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $112.35M derived: sum of 2 quarters · filed 2025-11-05 | $120.34M 10-Q · filed 2025-11-05 | $123.91M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $111.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $119.47M 10-Q · filed 2025-08-07 | $123.03M derived: sum of 3 quarters · filed 2026-02-25 | $114.79M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $7.99M 10-Q · filed 2025-05-07 | $11.55M derived: sum of 2 quarters · filed 2026-02-25 | $3.32M derived: sum of 3 quarters · filed 2026-02-25 | $4.21M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$4.67M derived: sum of 2 quarters · filed 2026-02-25 | -$3.78M derived: sum of 3 quarters · filed 2026-02-25 | $61.52M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$8.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$7.34M derived: sum of 2 quarters · filed 2024-11-07 | $57.96M 10-Q · filed 2024-11-07 | $64.27M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $891.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $66.20M 10-Q · filed 2024-08-05 | $72.50M derived: sum of 3 quarters · filed 2025-02-25 | $72.05M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $65.31M 10-Q · filed 2024-05-06 | $71.61M derived: sum of 2 quarters · filed 2025-02-25 | $71.16M derived: sum of 3 quarters · filed 2025-02-25 | $71.73M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.85M derived: sum of 2 quarters · filed 2025-02-25 | $6.43M derived: sum of 3 quarters · filed 2025-02-25 | $6.33M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$455.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $123.00K derived: sum of 2 quarters · filed 2023-11-09 | $25.00K 10-Q · filed 2023-11-09 | $429.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $578.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $480.00K 10-Q · filed 2023-08-07 | $884.00K derived: sum of 3 quarters · filed 2023-08-07 | $121.43M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$98.00K 10-Q · filed 2023-05-09 | $306.00K derived: sum of 2 quarters · filed 2023-05-09 | $120.85M derived: sum of 3 quarters · filed 2023-05-09 | $131.10M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $120.95M derived: sum of 2 quarters · filed 2023-03-06 | $131.20M derived: sum of 3 quarters · filed 2023-03-06 | $137.34M 10-K · filed 2023-03-06 |
| 2021-09-30 | $120.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $130.79M derived: sum of 2 quarters · filed 2022-11-07 | $136.94M 10-Q · filed 2022-11-07 | $161.27M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $10.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $16.39M 10-Q · filed 2022-08-08 | $40.72M derived: sum of 3 quarters · filed 2022-08-08 | $40.77M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $6.14M 10-Q · filed 2022-05-05 | $30.47M derived: sum of 2 quarters · filed 2022-05-05 | $30.52M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $24.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $24.38M derived: sum of 2 quarters · filed 2022-03-08 | $25.24M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $909.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $857.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |